BOLA2

BOLA2 is a cytosolic [2Fe-2S] cluster chaperone that functions in iron-sulfur cluster assembly and iron homeostasis. Apo BOLA2 binds to [2Fe-2S]-loaded Glrx3 to form a heterotrimeric complex (two BOLA2 molecules bridging two [2Fe-2S]²⁺ clusters on one Glrx3), which transfers intact clusters to the acceptor apoprotein Ciapin1/anamorsin in the cytosolic Fe-S assembly pathway (PMID:22309771, PMID:26613676, PMID:27519415). Upstream, BOLA2 receives iron through a PCBP1–Fe–GSH–BOLA2 intermediate complex that couples the ferrous iron chaperone system to Fe-S cluster biogenesis (PMID:31406370, PMID:34161287). Bola2-deficient mice exhibit iron-deficiency anemia with decreased hemoglobin, microcytosis, and altered zinc-protoporphyrin-to-heme ratios, establishing BOLA2 as essential for systemic iron homeostasis and erythropoiesis in vivo (PMID:31668704).

1. 2012 High

   The first question was whether human BOLA2, like its yeast ortholog, could coordinate iron-sulfur clusters with Glrx3; biophysical reconstitution showed that apo BOLA2 binds each Grx domain of [2Fe-2S] Glrx3 to form bridged heterodimeric/heterotrimeric complexes with coordination environments matching the yeast system, establishing BOLA2 as a bona fide Fe-S cluster-binding protein in humans.

   Evidence UV-visible, CD, resonance Raman, and EPR spectroscopy of recombinant human BOLA2–Glrx3 complexes

   PMID:22309771

   Open questions at the time

   • No demonstration that the complex existed or functioned in living cells
   • No downstream acceptor protein identified for the assembled cluster
   • Stoichiometry and structural details at atomic resolution not yet resolved
2. 2015 High

   NMR-level structural characterization resolved the heterotrimeric stoichiometry (2 BOLA2 : 1 GRX3 : 2 [2Fe-2S]²⁺) and demonstrated that this complex transfers both clusters to apo-anamorsin (Ciapin1), identifying the first physiological acceptor and establishing BOLA2–Glrx3 as a functional Fe-S chaperone.

   Evidence NMR spectroscopy, UV-visible/CD spectroscopy, and in vitro [2Fe-2S] cluster transfer assay with mutagenesis

   PMID:26613676

   Open questions at the time

   • Transfer demonstrated only in vitro; cellular validation still needed
   • Whether other acceptor proteins beyond anamorsin exist was unknown
   • Source of iron for initial cluster loading on the complex was unresolved
3. 2016 High

   Cellular validation confirmed that the Glrx3–BOLA2 interaction is Fe-S cluster–dependent and iron-responsive in vivo (6–8-fold increase upon iron supplementation), and that the complex transfers [2Fe-2S] clusters to Ciapin1 in intact human cells, establishing the chaperone function in a physiological context.

   Evidence Quantitative immunoprecipitation, BioID proximity labeling, iron perturbation, and cell-based Fe-S transfer assays in human cells

   PMID:27519415

   Open questions at the time

   • The iron source feeding into the BOLA2–Glrx3 complex remained unidentified
   • Full spectrum of cellular Fe-S acceptor targets unknown
   • In vivo organismal relevance not yet tested
4. 2016 Medium

   Comparative genomics revealed that BOLA2 was duplicated specifically in Homo sapiens ~282 kya and that copy number correlates with protein expression, raising the question of whether copy-number variation has functional consequences for iron metabolism.

   Evidence Comparative genomic analysis with RNA and protein expression quantification across individuals with variable BOLA2 copy number

   PMID:27487209

   Open questions at the time

   • Correlative data; no functional assay linking copy number to iron phenotype
   • The human-specific fusion transcript's function was not characterized
   • No direct experimental test of duplication's impact on Fe-S pathway
5. 2019 High

   Two key advances closed major gaps: (1) PCBP1 was identified as the upstream iron donor, forming a PCBP1–Fe–GSH–BOLA2 intermediate that channels ferrous iron into [2Fe-2S] cluster assembly on BOLA2–Glrx3; (2) Bola2-deficient mice exhibited iron-deficiency anemia, directly demonstrating BOLA2's requirement for systemic iron homeostasis and erythropoiesis in vivo.

   Evidence (1) Proteomics, in vitro reconstitution, mutagenesis, and cell-based assays; (2) Bola2 knockout/heterozygous mouse models with hematological profiling

   PMID:31406370 PMID:31668704

   Open questions at the time

   • Whether PCBP1–BOLA2 interaction is the sole route for iron entry into cytosolic Fe-S assembly is unknown
   • Tissue-specific roles of BOLA2 beyond erythropoiesis not explored
   • Structural basis of the PCBP1–Fe–GSH–BOLA2 intermediate not resolved
6. 2021 High

   Domain-specific mutagenesis of PCBP1 iron-coordinating residues showed that each PCBP1 domain contributes distinct iron-liganding sites required for BolA2 binding, and that the iron chaperone activity of PCBP1 (including its interaction with BOLA2) controls cell cycle progression and suppresses DNA damage independently of nucleic acid binding.

   Evidence Mutagenesis of PCBP1 iron-coordinating residues, co-immunoprecipitation, KO/KD in human cells and mouse tissues, cell cycle and DNA damage assays

   PMID:34161287

   Open questions at the time

   • Whether BOLA2 itself directly mediates cell cycle or DNA damage effects, or whether these are downstream of general Fe-S deficiency, is unresolved
   • Structural model of the PCBP1–BOLA2 interface lacking
7. 2025 Medium

   BOLA2 transcription was shown to be directly regulated by STAT5, placing BOLA2 downstream of β1 integrin–STAT5 signaling; BOLA2 overexpression conferred resistance to doxorubicin-induced apoptosis in breast cancer cells, linking Fe-S chaperone function to apoptotic regulation via the CIAPIN1 pathway.

   Evidence EMSA, luciferase reporter assay, BOLA2 overexpression with apoptosis assay, β1 integrin rescue experiment in breast cancer cells

   PMID:41465298

   Open questions at the time

   • Single-lab finding; transcriptional regulation by STAT5 not independently confirmed
   • Whether BOLA2's anti-apoptotic effect requires its Fe-S chaperone activity or operates through a distinct mechanism is untested
   • Relevance of STAT5 regulation to normal erythropoietic BOLA2 function not examined

• Key unresolved questions include: whether BOLA2 delivers [2Fe-2S] clusters to acceptors beyond Ciapin1/anamorsin, how BOLA2 copy-number variation in humans functionally impacts iron metabolism, and the structural basis of the PCBP1–Fe–GSH–BOLA2 handoff intermediate.
• Full repertoire of Fe-S acceptor proteins for BOLA2–Glrx3 unknown
• No high-resolution structure of the PCBP1–BOLA2 intermediate complex
• Functional consequences of human-specific BOLA2 copy-number expansion on Fe-S metabolism not directly tested